Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study

Marios C Pantzaris; Christos Bakirtzis; Nikolaos Grigoriadis; Georgios Hadjigeorgiou; Efthimos Dardiotis; George Loucaides; Evangelia Ntzani; Georgios Markozannes; Savvas Omorfos; Paola Valsasina; Roberta Messina; Paolo Preziosa; Maria A Rocca; Ioannis Patrikios

doi:10.1136/bmjno-2022-000334

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

PDF +
Supplementary
Material

Original research

Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study

Online download statistics by month:

Online download statistics by month: November 2022 to May 2023

	Abstract	Full	Pdf
Nov 2022	496	501	130
Dec 2022	274	272	54
Jan 2023	159	163	16
Feb 2023	273	277	48
Mar 2023	127	130	21
Apr 2023	122	123	21
May 2023	135	135	16
Total	1586	1601	306

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: November 2022 to May 2023

Read the full text or download the PDF:

Log in using your username and password